New! Anticoagulation Therapy Management for Pharmacists

This course is approved by the Florida Board of Pharmacy for 18.5 consultant recertification hours.

Program Details

  • Intended Audience: Pharmacists who have or want to prepare for the responsibility of monitoring and managing anticoagulation therapy patients and clinics.
  • Universal Activity Number: 0012-0000-22-040-H01-P
  • Contact Hours: 18.5 hours of ACPE continuing education for pharmacists
  • Program Fees: $699.00
  • UAN Release Date: 11/16/2022
  • UAN Expiration Date: 11/16/2025
  • Activity Type: Practice/Certificate Program
  • Program Support: No outside financial support was provided.
  • Format Type: This course is self-paced, fully online.
  • Time to Complete: All coursework must be completed within 16 weeks from the date of registration or before date of UAN expiration, 11/16/2025, whichever comes first. This course will no longer be eligible for CE credit after 11/16/2025.


This course is designed as a resource to help prepare the pharmacist for the responsibility of monitoring and managing anticoagulation therapy patients and clinics. It is also designed to serve as a starting point to help the pharmacist prepare for the Certified Anticoagulation Care Provider (CACP) exam.

This course is approved by the Florida Board of Pharmacy for 18.5 contact hours to meet requirements pursuant to CHAPTER 64B16-26, Florida Statutes, and Rule 64B16-26.300, Florida Administrative Code. Participants who successfully complete the program will also receive a certificate of completion.

Program Overview

Module 1: Overview of anticoagulant medications

The educational material will provide an overview of medications commonly used in the management of anticoagulation therapy.  Content will specifically cover the history of anticoagulant medications; discuss the clotting pathway; and review the pharmacology of warfarin, Direct Oral Anticoagulants (DOACS), and unfractionated heparin/low-molecular weight heparins. An overview of patient education concepts and pharmacist impact on anticoagulation management will also be reviewed.

Module 2: Disease state management and special populations

The educational material will discuss the antithrombotic/thrombolytic management of commonly encountered disease states requiring antithrombotic/thrombolytic therapy.  Program content will also discuss the management of anticoagulation related to pregnancy and pediatrics.  Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states and special populations reviewed.

Module 3: Anticoagulation Complications and Periprocedural Management

The educational material will provide information on the management of complications that may occur with the use of anticoagulant medications, including considerations for management of bleeding, reversal of anticoagulation, and the management of Heparin Induced Thrombocytopenia.  Programmatic content will also discuss the management of anticoagulants in the perioperative setting. Learners will be provided the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of simulated clinical scenarios.

Module 4: Operational Components of Anticoagulation Management

The educational material will review the operational and administrative topics related to anticoagulation management.  These topics discussed include the development and design of an anticoagulation clinic, considerations for billing and reimbursement for services, and the use of point of care devices for INR testing.

Program Objectives

At the completion of this activity, the participant will be able to:

  • Analyze the normal process of hemostasis and discuss disruptions in this process in pathologic conditions.
  • Compare the indications, mechanism of action, appropriate dosing, and appropriate monitoring for anticoagulant medications for various indications.
  • Explain pertinent disease state, drug/drug and drug/food interactions and adverse effects with anticoagulant medications.
  • Develop a complete anticoagulant treatment plan for patients with various indications.
  • Construct a process for managing anticoagulants and related complications during medical procedures.
  • Plan management and operational aspects of pharmacists-managed anticoagulation services.

Program Faculty

A full list of the program faculty can be found on the speaker page.

Disclosure Statement

The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

  • Rachel Shaddock, Pharm.D.
  • Katherine Vogel Anderson, Pharm.D., BCACP
  • Adonice Khoury, Pharm.D., BCPS 
  • Joseph J. Fierro, Pharm.D., BCACP
  • Kaitlin M. Alexander, Pharm.D.
  • Stacy A. Voils, Pharm.D., MS, BCPS, FCCM
  • Kalen B. Manasco, PharmD, BCPS, FCCP, FPPAG
  • James Taylor, Pharm.D., CDE, BCACP
  • Julie Nickerson-Troy, Pharm.D., MS, BCACP & Kristin Morse, Pharm.D.

Schedule of Activities and Requirements for Successful Course Completion

To successfully pass this course the participant must complete the following: 

  • View all recorded lectures
  • Complete all learning assessments 
  • Complete all case assignments

All program content must be submitted and the participant must achieve a passing score of 70% or more on all course assignments to receive continuing education credit and a certificate of completion.  Pharmacists are given 16 weeks from the date of registration to complete the course.  

The Office of Continuing Pharmacy Education can mail you a printed certificate of completion for an additional $25.00.  
Contact us for more information.

Additional Resources

Please review the resources below before registering for the course.

ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.